1. Gregory S. Gordon
975 Chateau Meadows Dr PH# 541-915-5727
Eugene, Oregon. 97401 FAX 541-686-3296
Email: greggordon08@gmail.com
Sales consultant; Medical Device, Surgical Supplies, Biotech/Pharma
Key Account Management ◊ New Business/Territory Development ◊ Consultative and Solution Sales
Relationship Building ◊ Contract Negotiating
PROFILE Accomplished 12 year sales career reflecting growth in territories new, expanded, and established, relative
to employers. Ability to create and drive new business in un-tapped or underserved accounts while
supporting growth in key established accounts. Proficient in most Hospital/Surgical business including
Capital Equipment, Disposables, Instrumentation, Implants (spine/CMF/brain) and Biotech/Pharmaceuticals
Areas of Expertise
Neurosurgery Orthopedic Surgery ENT/OTO
Oral/Maxillofacial Surgery Plastic/Reconstructive Surgery
Areas of Strength
Cardiothoracic Ophthalmology Urology/OBGYN General Surgery
Exceptionally well organized with skills to flourish at all levels of autonomy.
Self-motivated and creative with initiative to achieve personal and corporate goals.
PROFESSIONAL EXPERIENCE
July 2008 – Feb. 2010 Bayer Corporation – Hospital Surgical Division
POSITION ELIMINATED THROUGH CORPORATE RESTURCTURING
Recruited to promote (co-promote) launch of Recombinant topical hemostat, and direct Factor 10a- inhibitor for
total hip and total knee patients. Territory initially included Oregon, Washington, Idaho, and Montana, restructured
to Oregon and then eliminated as Diagnostic Imaging Division absorbed Hospital Surgical Division. Factor
10a – inhibitor delayed twice by FDA and has yet to launch.
Key Accomplishments:
• Achieved ranking of 22/60 (re-aligned from 5/60) 1 year, territory had zero dollars in sales when hired.
• Established accounts in multiple states before territory restructured
Aug. 2006 – July 2008 TKO Surgical Distributor – Southern Oregon
Premier Distributor in the Northwest. Due to growth needs, expanded new position to serve all accounts south
of Portland, OR. Established growth in key capital, disposable and implant business, as well as growth in many
of TKO Surgical ancillary products. Interface directly with top-level decision makers on high dollar contracts
,and coordinate process from contract completion to product implementation in the O.R.
Product Profile: Leica Surgical Microscopes ◊ Anspach Surgical Drill ◊ DuraSeal ◊
Welch Allyn Surgical Lighting◊ V-Mueller instruments ◊ Aesculap Spine ◊ Spinal Elements
◊ Olsen electrosurgical ◊ Sophysa VP Shunts ◊ Ostene ◊ Micro-Tec ◊ Spetzler Surgical Patties
2008 TYD (thru Aug.) total dollars in sales. $ 1.2 Million. Key Product Numbers;
• Anspach- $332K Quota $ 545K
• Leica $480K Quota $ 600K
• DuraSeal $190K Quota $ 291K
• Sophysa $13K Quota $ 35K
• V-Mueller $26K Quota $100K
• Aesculap $77K Quota $135K
• Welch Allyn Surgical Headlights $106K. no quota
Complete 2007 sales numbers available upon request. Total 2007 Sales $1.23 Million

2. Gregory S. Gordon page 2
TKO Surgical, Cont.
Key Accomplishments:
• Negotiated key capital purchases for new hospital in Eugene, Oregon, including Microscopes, Drills and
Surgical Headlights
• Growth in both capital and disposable for Anspach Surgical Drills and Burrs
• Convert key accounts from competitive products to DuraSeal
May 2003- Aug 2006 Synthes CMF – Southern Oregon
Due to growth, territory created to provide support to key accounts south of Portland, OR. Facilitate product from
Surgeon request to Surgical Supply management to O.R. Implemented conversion process through education
and in-service including Synthes Bone Lab CME plating courses.
Sales Achievements;
• 2006 –44% Quota, NA% $200K in sales through Aug
• 2005 –102% Quota 11% growth $450K in sales
• 2004 –136% Quota, 68% growth $333K in sales
• 2003 - 68% Quota, -46% YTD growth $183K in sales (5 mo. In territory)
Key Accomplishments:
• Conversion and Standardization of 75% or greater in key accounts
• Continued growth in Key Product Segments each year
Aug.2000-May 2003 Bayer Corporation. Anti-Infective/CV Division So. Oregon
Entry-level pharmaceutical position. Maintained accounts and provided product samples and education to
Family Practice, Internal Medicine and Cardiovascular physicians. Promoted antibiotics Cipro and Avelox.
Also promoted Statin Baycol until withdrawn from market. Territory rankings generally measured on prescription
volume.
June 1998-Aug.2000 Warner Chilcott Labs. Women’s Health/Urology
Entry-level position in new territory for Warner Chilcott. Company had no Oregon representation before.
Provided educational information and samples of Warner Chilcott products Natafort, Ovcon 35,
Pyridium Plus and Estrace.
EDUCATION AND TRAINING
Bachelor of Science; Health Sciences / Anatomy and Physiology
Northeastern University, Bouve College of Allied Health Sciences. Boston MA. 1994
• Internship: Liberty Mutual Medical Center. Jan. – Mar. 1991 / July-Dec. 1993
TECHNICAL SKILLS
• Successful completion of St. Louis University Hospital June 2005
Cadaver Skull Based Practical Anatomy Workshop (PAWS)
• Anspach Surgical Drill, Bone Dissection Lab Oct. 2006
• Successful completion of Covidian DuraSeal Skull Based Aug. 2007
Cadaver Lab